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Surgical ﬁeld qualityAbstract Objective: Mucosal bleeding during FESS often interferes with optimal visualization of
the nasal surgical ﬁeld and can impair the safety and efﬁciency of the procedure. This study was
conducted to evaluate the efﬁcacy of tranexamic acid and Epsilon Aminocaproic Acid to decrease
bleeding and improve visualization of the surgical ﬁeld during FESS.
Materials and methods: A total of 90 patients ASA I-II aged from 18 to 50 years and undergoing
FESS for chronic sinusitis were enrolled in this study. Surgery was performed under general anes-
thesia patients were randomly assigned to three equal groups (30 patients each), patients in TXA
group received intravenous tranexamic acid 10 mg/kg diluted in 100 ml saline. EACA group
received intravenous Epsilon Aminocaproic Acid 100 mg/kg diluted in 100 ml saline and the control
group received IV 100 ml normal saline (all infusions were through 10 min). The duration of sur-
gery, volume of blood loss, pre and postoperative hemoglobin, MAP and HR, surgical ﬁeld quality
surgeon satisfaction and side effects were recorded.
Results: The duration of surgery was signiﬁcantly less in TXA and EACA groups than the control
group (121.1 ± 7.1 min), (120.8 ± 6.0 min), versus (146.1 ± 7.3 min) volume of blood loss in TXA
group and EACA group was comparable (195.3 ± 32.2 ml) and (201.5 ± 30.6 ml) but each of them
has signiﬁcant less blood loss than the control group (365.1 ± 48.8 ml). The postoperative hemo-
globin was signiﬁcantly lower in the control group (11.9 ± 0.4 gm/dl) compared to TXA group
(12.6 ± 0.2 gm/dl) and EACA group (12.4 ± 0.2 gm/dl). Both TXA and EACA groups had com-
parable improved quality of the surgical ﬁeld with most of patients classiﬁed as grade 1 and 2
according to Boezaart scale while the control group had most of patients in grade 3, accordingly
the surgeon satisfaction is signiﬁcantly higher in TXA and EACA groups compared to the control
group. No signiﬁcant difference in side effects between all groups.
2 S.M. El Shal, R. HasaneinConclusion: Intravenous tranexamic acid and Epsilon Aminocaproic Acid (EACA) effectively
reduce bleeding during FESS and improve visualization of the surgical ﬁeld and so increase the sur-
geon satisfaction with no signiﬁcant difference between both drugs.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Functional endoscopic sinus surgery is a skillful minimally
invasive surgical technique widely used for management of
chronic rhinosinusitis and chronic polypous rhinosinusitis.
Mucosal bleeding often interferes with optimal visualization
of the nasal surgical ﬁeld [1] and can impair the safety and efﬁ-
ciency of the procedure, as it may prolong the duration of sur-
gery due to the need for frequent suctioning, or increase the
incidence of surgical complications as injury of orbital vascu-
lature [2].
Many factors including arterial blood pressure, heart rate,
and coagulation disorders have great effect on bleeding in
FESS, so various maneuvers are used to decrease bleeding
and provide clear surgical ﬁeld, e.g. local vasoconstrictors,
elevation of the patient’s head, use of beta blockers and con-
trolled hypotensive anesthesia [3]. In some patients bleeding
cannot be controlled by the previous techniques and other
alternatives are required, one of them is the use of antiﬁbrino-
lytic drugs as tranexamic acid and Epsilon Aminocaproic Acid
(EACA), previous studies proved the efﬁcacy of these agents to
reduce bleeding in patients undergoing cardiac surgery, major
orthopedic, spine and prostatic surgeries [4–6]. Some dental
surgeons used tranexamic acid as a mouthwash for dental
extractions [7]. Tranexamic acid and Epsilon Aminocaproic
Acid are synthetic derivatives of amino acid lysine that pro-
duce reversible blockade of lysine binding sites on plasminogen
molecules, so reducing the conversion of plasminogen to
plasmin which is responsible for the degradation of blood
clots [4,5].
This study was conducted to evaluate the efﬁcacy of two
antiﬁbrinolytic agents; Tranexamic acid and Epsilon Aminoca-
proic Acid (EACA) to control and limit bleeding and improve
visualization of the surgical ﬁeld during FESS procedures.2. Materials and methods
This randomized controlled comparative study was done in
ENT surgical theater in Kasr El-Ainy Hospital. The study
was approved by the hospital ethics committee, and a written
informed consent was taken from every patient during the pre-
operative visit.
A total of 90 patients aged from 18 to 50 years and undergo-
ing FESS for chronic sinusitis were enrolled in this study. All
patients were: ASA I and-II. Patients with uncontrolled hyper-
tension, renal or hepatic dysfunction, coronary or cerebral
artery disease, autonomic disturbance, deep vein thrombosis
or peripheral vascular disease, bleeding diathesis and patients
receiving anticoagulants were excluded from the study.
Patients were randomly assigned to three equal groups (30
patients each); TXA group to receive iv tranexamic acid,
EACA group to receive iv Epsilon Aminocaproic Acid andcontrol group to receive normal saline. Randomization was
done by means of computer-generated codes. The anesthesiol-
ogists, surgeons, and patients were blinded to study drugs, and
an anesthesiologist not involved in study prepared the infusion
drugs before induction of anesthesia.
After complete preoperative assessment (medical history,
vital signs, and airway assessment), patients were explained
about the procedure and advised to practice mouth breathing.
All routine preoperative investigations were assessed (ECG,
complete blood picture, kidney and liver functions), complete
coagulation proﬁle was assessed to exclude any coagulation
defects. Upon arrival to the operating room monitors were
applied (ECG, pulse oximeter, and non invasive measurement
of arterial blood pressure) and a venous cannula was inserted
on the dorsum of the hand. After application of 100% oxygen
at 5 l/min for 5 min – while asking the patient to practice
mouth breathing – anesthesia was induced with intravenous
fentanyl 1 lg/kg, propofol 2 mg/kg, lidocaine 1.5 mg/kg and
atracurium (0.5 mg/kg) to facilitate tracheal intubation with
a suitable size cuffed ETT, then an oropharyngeal pack was
inserted, and the patient was positioned with head up 30.
Anesthesia was maintained with isoﬂurane (1.5–2%), and
100% oxygen, controlled ventilation with a tidal volume of
10 ml/kg and respiratory rate of 10–12 breaths/min was
adjusted to maintain end tidal CO2 at 30–35 mmHg.
After induction of anesthesia, patients in TXA group
received intravenous tranexamic acid 10 mg/kg diluted in
100 ml saline administered during 10 min infusion. Patients
in EACA group received intravenous Epsilon Aminocaproic
Acid (EACA) 100 mg/kg diluted in 100 ml normal saline and
infused over 10 min. The control group received 100 ml normal
saline by intravenous infusion through 10 min. All the proce-
dures were performed by the same anesthesia and surgical
teams using the same surgical technique. Intraoperative moni-
toring included 5 leads ECG, arterial blood pressure (invasive
method after insertion of 20 gauge cannula in the radial artery
of the non dominant hand), pulse oximeter for arterial oxygen
saturation, and end tidal carbon dioxide was assessed by cap-
nogram. Moderate hypotensive anesthesia was used to main-
tain mean arterial pressure (MAP) around 55–65 mmHg
during surgery by adjusting isoﬂurane concentration (1.5–
2%) and infusion of nitroglycerine through a separate venous
cannula (0.5–5 lg/kg/min) and titration of rate of infusion
according to measurement of mean arterial blood pressure.
Intraoperative ﬂuid supply was obtained with 0.9% saline or
lactated ringer’s solution (3 ml/kg/h and replacement of blood
loss). At the end of surgery the oropharyngeal pack was
removed, good suctioning of blood and secretions from the
mouth was done under direct vision using the laryngoscope,
and reversal of muscle relaxants was done by neostigmine
0.05 mg/kg and atropine 0.02 mg/kg and extubation is
achieved when the patient is fully awake then the patient is
instructed to breath from his mouth.
Table 1 Boezaart et al. grading scale for scoring of surgical ﬁeld bleeding [8].
Grade Assessment
0 No bleeding
1 Slight bleeding: no suctioning required
2 Slight bleeding: occasional suctioning required
3 Slight bleeding: frequent suctioning required. bleeding threatens surgical ﬁeld a few seconds after suction is removed
4 Moderate bleeding: frequent suctioning required. bleeding threatens surgical ﬁeld directly after suction is removed
5 Severe bleeding: constant suctioning required .bleeding appears faster than can be removed by suction. surgical ﬁeld severely
threatened and surgery usually not possible
Effect of intravenous tranexamic acid and epsilon aminocaproic acid on bleeding 33. During the procedure the following data were assessed and
recorded
 Intraoperative blood loss monitored directly from the col-
lection into the calibrated bottle in the suction apparatus
(100 ml graded suction canister) and the amount of irriga-
tion solution used during the procedure was subtracted
from the total amount of ﬂuid accumulated in the suction
device, also the volume of blood loss recorded by counting
the number of cotton strips used during surgery, a fully
soaked cotton strip was estimated to contain 5 ml blood
and partially soaked one contains 2.5 ml blood.
 Duration of operation (from induction to extubation).
 Assessment of nitroglycerine requirement.
 Pre- and postoperative hemoglobin concentration.
 Hemodynamic parameters: mean arterial blood pressure
(MAP) and heart rate (HR) were recorded before induction
of anesthesia as a base line, after induction of anesthesia,
and recorded every 15 min till the end of surgery.
 Assessment of the quality of the surgical ﬁeld by the sur-
geon with a predeﬁned scale (Boezaart scale) at half an hour
interval (Table 1) [8].
 The surgeon satisfaction with the surgical ﬁeld quality was
graded by 5 items Likert scale as 1: not satisﬁed at all, 2:
slightly satisﬁed, 3: moderately satisﬁed, 4: very satisﬁed,
5: extremely satisﬁed [9].
 The incidence of any side effects e.g., nausea, vomiting,
pruritus, fever, postoperative epistaxis and clinical evidence
of thrombus development was assessed for at least 24 h.
4. Statistical analysis
Data were analysed using IBM SPSS Advanced Statistics ver-
sion 20.0 (SPSS Inc., Chicago, IL). Numerical data were
expressed as mean and standard deviation. Chi-square test
(Fisher’s exact test) was used to examine the relation betweenTable 2 Demographic data and duration of surgery of the 3 group
TXA group (n= 30) EACA
Age (years) 36.5 ± 6.9 35.8 ±
Sex (male/female) 22/8 25/5
Body weight (kg) 69.9 ± 6.6 68.7 ±
Duration of surgery (min) 121.1 ± 7.1a 120.8
Data are presented as means and standard deviation or numbers.
Groups with different superscript letters are signiﬁcantly different.qualitative variables. For quantitative data, comparison
between the 3 groups was done using ANOVA test, then post-
Hoc ‘‘Schefe test’’ was used for pair-wise comparison. A p-value
<0.05 was considered signiﬁcant.
Power analysis was done based on volume of blood loss and
bleeding score of 3 between the 3 study groups. For volume of
blood loss, Student’s t test for independent samples was chosen
to perform the analysis, the power of statistical comparison
was 19% in between TXA and EACA, while it was more than
95% if comparing between either TXA, or EACA to control
group, while Fisher Exact test was chosen for bleeding score
3. The power of statistical comparison between TXA and
EACA was less than 20%, while it was more than 95% if done
between either of them and the control group. a-error level was
ﬁxed at 0.05 and the sample size was entered to be 30 partici-
pants in each group. Calculations were done using PS Power
and Sample Size Calculations Software, version 3.0.11 for
MS Windows (William D. Dupont and Walton D. Vanderbilt,
USA).5. Results
A total number of 90 patients aged from 18 to 50 years were
enrolled in this study. No signiﬁcant differences were noted
between the three groups in the study as regards the demo-
graphic data, but the duration of surgery was signiﬁcantly less
in tranexamic acid and EACA groups than the control group
(121.1 ± 7.1 min), (120.8 ± 6.0 min), versus (146.1 ± 7.3 min)
(Table 2).
As for nitroglycerine requirement it showed no signiﬁcant
difference between TXA group (12.6 ± 2.5 mg) EACA group
(12.4 ± 2.4 mg) and control group (12.6 ± 2.7 mg). Volume
of Blood loss in TXA group and EACA group was comparable
with no signiﬁcant difference between both groups
(195.3 ± 32.2 ml) and (201.5 ± 30.6 ml) (p= 0.822) but each
of them has signiﬁcant lower amount of blood loss as com-
pared to control group (365.1 ± 48.8 ml) (Table 3).s.
group (n= 30) Control group (n= 30) p Value
5.8 36.3 ± 5.5 0.900
23/7 0.638
5.8 68.4 ± 5.9 0.621
± 6.0a 146.1 ± 7.3b <0.001
Table 3 Pre- and postoperative hemoglobin concentration and volume of blood loss in the three studied groups.
TXA group (n= 30) EACA group (n= 30) Control group (n= 30) p Value
Preoperative hemoglobin (g/dl) 13.3 ± 0.2 13.2 ± 0.3 13.2 ± 0.4 0.632
Postoperative hemoglobin (g/dl) 12.6 ± 0.2a 12.4 ± 0.2a 11.9 ± 0.4b <0.001
Volume of blood loss (ml) 195.3 ± 32.2a 201.5 ± 30.6a 365.1 ± 48.8b <0.001
Data are presented as means and standard deviation.
Groups with different superscript letters are signiﬁcantly different.
Figure 1 Mean arterial blood pressure (mmHg) between the study groups over the study period.
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Figure 2 Mean HR (beats/min) between the study groups over the study period.
4 S.M. El Shal, R. HasaneinThe postoperative hemoglobin concentration was signiﬁ-
cantly lower in the control group (11.9 ± 0.4 gm/dl) compared
to TXA group (12.6 ± 0.2 gm/dl) and EACA group
(12.4 ± 0.2 gm/dl) with no signiﬁcant difference between the
latter two groups (Table 3).
The MAP and HR were comparable in the three groups
with no statistically signiﬁcant differences between them. How-
ever, all values were within the clinically accepted ranges
(Figs. 1 and 2).
The quality of the surgical ﬁeld depending on Boezaart
scale is shown in Table 4. There were no signiﬁcant difference
between TXA and EACA groups in all measurement times as
most of patients were classiﬁed as grades 1 and 2, while the
control group had most of patients in grade 3 with signiﬁcant
difference relevant to the other two groups, no patient was
found in grade 4 or 5 in all groups.
The surgeon satisfaction of the surgical ﬁeld during surgery
based on ﬁve points Likert scale also showed no signiﬁcant dif-ference between TXA and EACA group, but both groups
showed signiﬁcantly higher satisfaction compared to control
group (Table 5).
The three groups were comparable as regards the side
effects. Only 4 patients in TXA group and 3 patients in EACA
group have nausea and vomiting compared to 3 patients in
control group, no patient had postoperative epistaxis in
TXA and EACA groups, while there was one case in the con-
trol group. None of the patients showed signs or symptoms of
thromboembolic events.6. Discussion
During endoscopic sinus surgery, excessive bleeding represents
a major problem for both the surgeon and the anesthesiologist.
Bleeding is difﬁcult to control in this procedure due to anatom-
ical and surgical reasons.
Table 5 Surgeon satisfaction according to Likert’s scale (5 points scale).
Measurement times TXA group (n= 30) EACA group (n= 30) Control group (n= 30) p Value
30 min 3.9 ± 0.9a 3.8 ± 0.9a 2.8 ± 1.2b <0.001
60 min 4.0 ± 0.6a 3.8 ± 0.8a 3.2 ± 0.4b <0.001
90 min 3.8 ± 0.7a 3.7 ± 0.6a 3.2 ± 0.2b <0.001
120 min 3.8 ± 0.5a 3.8 ± 0.7a 3.3 ± 0.2b <0.001
150 min 4.0 ± 0.5a 4.3 ± 0.7a 3.4 ± 0.6b <0.001
Data are expressed as means ± SD.
Groups with different superscript letters are signiﬁcantly different.
Table 4 Quality of the surgical ﬁeld according to Boezzart scale.
Time of assessment (min) Grade TXA group (n= 30) EACA group (n= 30) Control group (n= 30) p Value
30 0–1 10 9 1 <0.001
2 12 12 6
3 8 9 23
60 0–1 2 1 1 0.013
2 18 16 7
3 10 13 22
90 0–1 19 16 4 <0.001
2 9 10 5
3 2 4 21
120 0–1 17 16 4 <0.001
2 10 9 6
3 3 5 20
150 0–1 18 18 5 <0.001
2 10 8 5
3 2 4 20
Data were expressed as number of patients.
Effect of intravenous tranexamic acid and epsilon aminocaproic acid on bleeding 5There is a great role of the anesthesiologists in improving
the surgical conditions to achieve bloodless ﬁeld for better
visualization of the intranasal structure [10], and to avoid the
risk of surgical complications as damage of orbit or optic
nerve, unintended penetration of the middle cranial fossa, or
even damage of internal carotid artery. FESS is better done
under general anesthesia and several methods were used to
reduce surgical ﬁeld bleeding e.g. reverse trendelburg position
up to 30, local mucosal vasoconstrictors, and controlled
hypotension [3].
In this study antiﬁbrinolytic drugs (Tranexamic acid and
Epsilon Aminocaproic Acid) were used as i.v adjuvants to
decrease the surgical ﬁeld bleeding, and improve visualization.
There was a signiﬁcant decrease in the volume of intraopera-
tive blood loss, and duration of surgery with signiﬁcant
improvement in the quality of the surgical ﬁeld in both groups
(TXA and EACA) compared to the control group.
Tranexamic acid and Epsilon Aminocaproic Acid are
widely and effectively used to reduce blood loss and subse-
quent need for blood transfusion in oral, orthopedic, spinal,
cardiac surgery, liver transplantation and prostate surgery
[11–13].
Tranexamic acid (TXA) and Epsilon Aminocaproic Acid
(EACA) are synthetic lysine analogs and act as inhibitors of
ﬁbrinolysis as they bind to the lysine binding sites on plasmin-
ogen, inhibiting binding to ﬁbrin, and thus suppressing the
whole process of ﬁbrinolysis. These agents inhibit the naturaldegradation of ﬁbrin and so stabilize clots [10], they have no
effect on blood coagulation parameters [12].
The dose of antiﬁbrinolytic drugs in the present study was
within the dose range previously found to be effective, it has
been proved that the mean duration of the effect of TXA
and EACA is approximately 3 h. Considering the relatively
short duration of FESS, so a single bolus dose of either drug
was used, others in cardiac or orthopedic surgery used contin-
uous infusion after the bolus dose [13].
In this study there was no signiﬁcant difference between all
groups as regards the demographic characteristics, the MAP,
and HR, and nitroglycerine requirements, and these results
are concomitant with study of Alimian et al. [9] that compared,
the effect of 10 mg/kg tranexamic acid with placebo in 84
patients randomized into two equal groups and undergoing
FESS, there was no signiﬁcant difference in MAP, HR
between both groups. Another study done by Abbasi et al.,
who compared the effect of two doses of intravenous tranex-
amic acid on two equal groups with 35 patients in each group
were scheduled for endoscopic sinus surgery under general
anesthesia, where group A received 5 mg/kg of TXA, while
another 35 patients (group B) received 15 mg/kg iv TXA, no
signiﬁcant difference was found in MAP and HR between both
groups in all measuring times [14].
The duration of surgery was signiﬁcantly less in both TXA
and EACA groups compared to the control group. Also, the
amount of blood loss was signiﬁcantly less in both TXA and
6 S.M. El Shal, R. HasaneinEACA groups (195.3 ± 32.2 ml), (201.5 ± 30.6 ml) compared
to the control group (365.1 ± 48.8 ml), these results were in
agreement with those of previous study of Alimian et al. [9].
Where blood loss in TXA group (184 ± 64 ml) was signiﬁ-
cantly less than the placebo group (312 ± 75 ml) and
p< 0.01.
Moise et al. used tranexamic acid 10 mg/kg, compared to
saline group (30 patients in each group, the patients were
undergoing FESS under general anesthesia, the study group
received 10 mg/kg tranexamic acid in 10 ml saline solution
and the control group received 10 ml saline solution with
two administrations: before induction and before nasal pack
removal, the results proved that the total blood loss intraoper-
atively and postsurgically decreased up to 50% level in the
study group compared to the control group [15].
The postoperative Hb concentration was signiﬁcantly lower
in the control group (11.9 ± 0.4) compared to TXA group
(12.6 ± 0.2) and EACA group (12.4 ± 0.2) this is in agree-
ment of the study of Abbas et al. who compared the effect
of tranexamic acid to placebo in 32 patients undergoing
bimaxillary osteotomy they received diluted tranexamic acid
(20 mg/kg) or equal volume of normal saline intravenously just
before induction of anesthesia, there was signiﬁcant reduction
in postoperative Hb of the control group 10.68 compared to
tranexamic acid group 11.56 g/dl [16].
Application of tranexamic acid or aminocaproic acid effec-
tively reduced the amount of blood loss during other types of
surgeries e,g orthopedic, cardiac, oral, and spine surgeries,
these ﬁndings were in agreement with this study [4–7].
Camarsa et al. [13] compared the efﬁcacy of aminocaporic
acid and tranexamic acid in control postoperative bleeding
on removal of pneumatic tourniquet during total knee replace-
ment the total blood loss was signiﬁcantly less in antiﬁbrino-
lytic group compared to control group (P< 0.01), no
signiﬁcant differences were found between EACA and TXA
groups for any of outcome measures, this ﬁnding was also cor-
related to our study.
In cardiothoracic surgery many studies also proved the
comparable effect of both drugs in reducing blood loss and
need for blood transfusion as that done by Netti et al. for
patients undergoing thoracic aortic surgery [17].
The difference of the nature of endoscopic nasal surgery as
FESS with limited anatomical space from orthopedic or car-
diac surgery requires the need to improve the visualization of
the surgical ﬁeld. Validated scales were used to evaluate surgi-
cal ﬁeld quality and surgeon satisfaction. In the current study
the surgeons were more satisﬁed with the surgical ﬁeld in TXA
and EACA groups than the control group this was evidenced
by using the Boezaart grading scale for scoring of surgical ﬁeld
bleeding as minimum or occasional suctioning required in all
measurement times and most of patients were in grade 1 and
2 of Boezaart scale in both TXA and EACA groups with no
signiﬁcant difference between both groups in contrast to the
control group which had most of patients in grade 3. Accord-
ingly the surgeon satisfaction assessment by Likert scale
showed that the surgeons were more satisﬁed with the surgical
ﬁeld in both TXA and EACA groups than the control group,
this result was correlated with that of Alimian et al. who com-
pared 10 ml/kg iv tranexamic acid with placebo, there was sig-
niﬁcant decrease in bleeding and higher surgeon satisfaction of
the visibility of the surgical ﬁeld in TXA group [9].The study of Jabalameli et al., and that of Yaniv et al. have
comparable results to the current study as regards the improve-
ment of quality of the surgical ﬁeld and reduced volume of
bleeding although they used topical and oral tranexamic acid
in FESS [18,19] this may be due to local antiﬁbrinolytic effect
of the drug.
Other studies were not supporting the results of the current
study as that of Mottaghi et al. [20] who compared 500 mg of
iv tranexamic acid with placebo in 50 patients undergoing
FESS, there were no signiﬁcant difference between both
groups as regards SBP, DBP, MAP, HR, and there were sim-
ilar results of changes in bleeding and surgeon satisfaction
scores, these results do not agree with the results of the current
study and other previous studies this may be related to differ-
ence in the surgical technique or difference in tissue hypertro-
phy, the different dose of tranexamic acid may also play a role
in this different results as the dose used in Mottaghi et al. study
was ﬁxed dose 500 mg which may be less than the dose used in
most studies.
On the other hand a study done by Athanasiadis et al. com-
pared 30 patients undergoing FESS, the patients were random-
ized into three groups to receive either 2.5 g of EACA, 100 mg
of TXA, or 1 g of TXA while the contralateral nasal side
received saline, the solution was applied as spray, bleeding
was documented using standardized videoscopy and grading
scales, it concluded that tranexamic acid can reduce surgical
site bleeding at 2, 4, 6 min after application, while the amino-
caproic acid has no signiﬁcant effect, this ﬁnding was different
from the current study, this may be related to difference in
method of application and time of assessment [21].
Another study of Kushaga et al. [22] comparing the effect
of iv TXA, EACA and placebo for corrective spinal surgery
where efﬁcacy was determined by intraoperative and postoper-
ative blood loss, they concluded that TXA is more effective in
reducing blood loss than EACA or placebo. these results are
contradicting with the comparable effect of TXA and EACA
detected in the current study and other studies as that of
Schauhan et al. [23] comparing TXA and EACA in adult car-
diac surgery, they concluded that both drugs are equally effec-
tive in reducing postoperative blood loss, also the study of
Makhija et al. [24] to evaluate efﬁcacy and safety of TXA ver-
sus EACA in patients undergoing thoracic aortic surgery in 64
adult patients with (CPB) where TXA group patients received
a bolus of 10 mg/kg of TXA followed by a maintenance infu-
sion of 1 mg/kg/h until chest closure while the EACA group
received a bolus of 50 mg/kg of EACA followed by a mainte-
nance infusion of 25 mg/kg/h until chest closure where they
found that cumulated mean blood loss and blood product
requirement were comparable.
The incidence of side effects in all groups was comparable,
they were related to nausea and vomiting (4 patient in TXA
group, 3 patients in EACA group and 3 patients in control
group), only one case of postoperative epistaxis in the control
group. No reported cases of clinical thromboembolic events
and this is comparable with all previous mentioned studies.
Although not performing echo-Doppler systematically on
patients enrolled in the study is considered as limitation of this
study but many previous studies and isolated case reports con-
sidered much higher doses of antiﬁbrinolytic drugs and contin-
ued the medication in the postoperative period with safe
outcome [9,13].
Effect of intravenous tranexamic acid and epsilon aminocaproic acid on bleeding 7Other limitation of the study is the exclusion of patients
with the bleeding diathesis or impaired coagulation proﬁle
from the study in which the use of antiﬁbrinolytic drugs could
limit the blood loss.
In conclusion this clinical study has demonstrated that both
intravenous tranexamic acid and aminocaproic acid effectively
reduce bleeding during FESS and improve visualization of the
surgical ﬁeld and so increase the surgeon satisfaction with no
signiﬁcant difference between both drugs. They are cheap
effective and safe drugs.
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